title: [Effects of dexamethasone on arsenic trioxide induced apoptosis, NF-kappaB activation and gene expression in lymphoma cell line].
abstract: OBJECTIVE
  To study the effect of dexamethasone (Dex) on the apoptosis and NF-kappaB activation in Raji cells as well as expression of MMP9 and VEGF induced by As2O3, and to observe the effect of inhibited activity of NF-kappaB by Dex on apoptosis.
  
  
  METHODS
  Cell apoptosis was analysed by Annexin V. Fluctuation of NF-kappaB, MMP9 and VEGF was detected by semi-quantitative immunohistochemistry.
  
  
  RESULTS
  The apoptosis and activation of NF-kappaB of Raji cells could be induced by As2O3. The percentage of apoptosis was (39.2 +/- 1.3)%. Dex significantly increased (77.5%) the apoptosis induced by As2O3 (P < 0.05). Dex suppressed the activation of NF-kappaB induced by As2O3 (a suppression rate of 28.0%, P < 0.05). There was a positive correlation between the changes of MMP9, VEGF and NF-kappaB.
  
  
  CONCLUSIONS
  As2O3 could induce apoptosis, activate NF-kappaB and up-regulate expression of MMP9 and VEGF of Raji cells. The mechanism of enhanced apoptosis by Dex may be related to suppressing activation of NF-kappaB and down-regulating expression of MMP9 and VEGF.
authors.affiliation: Department of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
authors.forename: Xiao-Wei
authors.initials: XW
authors.lastname: Xu
authors.forename: Xiao-Ping
authors.initials: XP
authors.lastname: Xu
authors.forename: Ke
authors.initials: K
authors.lastname: Yi
authors.forename: Li
authors.initials: L
authors.lastname: Chen
authors.forename: Shao-Yi
authors.initials: SY
authors.lastname: Chen
authors.forename: Fang
authors.initials: F
authors.lastname: Zhou
authors.forename: Qian-Yu
authors.initials: QY
authors.lastname: Li
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology*; D045744:Cell Line, Tumor; D003907:Dexamethasone / Q000494:pharmacology*; D004347:Drug Interactions; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000378:metabolism / Q000473:pathology; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D010087:Oxides / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis
chemical_list: D001152:Arsenicals; D005938:Glucocorticoids; D016328:NF-kappa B; D010087:Oxides; D042461:Vascular Endothelial Growth Factor A; D003907:Dexamethasone; D020780:Matrix Metalloproteinase 9; D000077237:Arsenic Trioxide